Ranolazine
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
27241-126 -
Package NDC
27241-126-02 -
Package NDC
27241-126-05 -
Application number
ANDA210054 -
SPL ID
933f695e-e4f4-4c75-80fc-aea9a30aa13d -
SPL set ID
8bfd1a61-547a-4847-ae4e-480b17da6272 -
UNII
A6IEZ5M406 -
RxCUI
616749 -
RxCUI
728231
What the source publishes
- Labeler
- Ajanta Pharma USA Inc.
- Active ingredients
- Ranolazine
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Ranolazine",
"splId": "933f695e-e4f4-4c75-80fc-aea9a30aa13d",
"labels": [
{
"setId": "8bfd1a61-547a-4847-ae4e-480b17da6272",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bfd1a61-547a-4847-ae4e-480b17da6272",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8bfd1a61-547a-4847-ae4e-480b17da6272"
}
],
"routes": [
"ORAL"
],
"labeler": "Ajanta Pharma USA Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-126-02)",
"package_ndc": "27241-126-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20190823"
},
{
"sample": false,
"description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-126-05)",
"package_ndc": "27241-126-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20210714"
}
],
"productId": "27241-126_933f695e-e4f4-4c75-80fc-aea9a30aa13d",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "27241-126",
"deaSchedule": null,
"genericName": "Ranolazine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "RANOLAZINE",
"strength": "1000 mg/1"
}
],
"applicationNumber": "ANDA210054",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20190823",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175427",
"N0000190114",
"N0000185503",
"N0000182137",
"N0000187061"
],
"upc": [
"0327241125027",
"0327241126024"
],
"unii": [
"A6IEZ5M406"
],
"rxcui": [
"616749",
"728231"
],
"spl_set_id": [
"8bfd1a61-547a-4847-ae4e-480b17da6272"
],
"pharm_class_epc": [
"Anti-anginal [EPC]"
],
"pharm_class_moa": [
"Cytochrome P450 3A Inhibitors [MoA]",
"P-Glycoprotein Inhibitors [MoA]",
"Cytochrome P450 2D6 Inhibitors [MoA]",
"Organic Cation Transporter 2 Inhibitors [MoA]"
],
"manufacturer_name": [
"Ajanta Pharma USA Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:27241-126_933f695e-e4f4-4c75-80fc-aea9a30aa13d"